AU2001296600A1 - Mini-dystrophin nucleic acid and peptide sequences - Google Patents

Mini-dystrophin nucleic acid and peptide sequences

Info

Publication number
AU2001296600A1
AU2001296600A1 AU2001296600A AU9660001A AU2001296600A1 AU 2001296600 A1 AU2001296600 A1 AU 2001296600A1 AU 2001296600 A AU2001296600 A AU 2001296600A AU 9660001 A AU9660001 A AU 9660001A AU 2001296600 A1 AU2001296600 A1 AU 2001296600A1
Authority
AU
Australia
Prior art keywords
mini
dystrophin
nucleic acid
peptide sequences
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296600A
Inventor
Jeffrey S. Chamberlain
Scott Q. Harper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of AU2001296600A1 publication Critical patent/AU2001296600A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • C07K14/4708—Duchenne dystrophy
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to compositions and methods for expressing mini-dystrophin peptides. In particular, the present invention provides compositions comprising nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins. The present invention also provides compositions comprising mini-dystrophin peptides, and methods for expressing mini-dystrophin peptides in target cells.
AU2001296600A 2000-10-06 2001-10-04 Mini-dystrophin nucleic acid and peptide sequences Abandoned AU2001296600A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23884800P 2000-10-06 2000-10-06
US60/238,848 2000-10-06
PCT/US2001/031126 WO2002029056A2 (en) 2000-10-06 2001-10-04 Mini-dystrophin nucleic acid and peptide sequences

Publications (1)

Publication Number Publication Date
AU2001296600A1 true AU2001296600A1 (en) 2002-04-15

Family

ID=22899572

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296600A Abandoned AU2001296600A1 (en) 2000-10-06 2001-10-04 Mini-dystrophin nucleic acid and peptide sequences

Country Status (6)

Country Link
US (3) US6869777B2 (en)
EP (1) EP1366160B1 (en)
AT (1) ATE400656T1 (en)
AU (1) AU2001296600A1 (en)
DE (1) DE60134786D1 (en)
WO (1) WO2002029056A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100422320C (en) * 2000-04-28 2008-10-01 肖啸 DNA sequences encoding dystrophin minigenes and methods of use thereof
CA2406687A1 (en) * 2001-11-09 2003-05-09 Transgene S.A. Chimeric promoters for controlling expression in muscle cells
AU2003225410A1 (en) 2003-03-21 2004-10-11 Academisch Ziekenhuis Leiden Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
US20070073264A1 (en) 2003-09-26 2007-03-29 The Trustees Of The University Of Pennsylvania Methods, compositions and apparatus for delivering heterologous molecules to cells
WO2005049850A2 (en) 2003-11-14 2005-06-02 University Of Washington Compositions and methods for systemic nucleic acid sequence delivery
WO2005118611A2 (en) * 2004-01-23 2005-12-15 The Trustees Of The University Of Pennsylvania Microutrophin and uses thereof
WO2006039218A2 (en) 2004-09-30 2006-04-13 The Trustees Of The University Of Pennsylvania Perfusion circuit and use therein in targeted delivery of macromolecules
US8071380B2 (en) * 2006-02-16 2011-12-06 Fondazione Centro San Raffaele Del Monte Tabor Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof
WO2007123391A1 (en) 2006-04-20 2007-11-01 Academisch Ziekenhuis Leiden Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene.
EP1857548A1 (en) 2006-05-19 2007-11-21 Academisch Ziekenhuis Leiden Means and method for inducing exon-skipping
WO2008018795A1 (en) 2006-08-11 2008-02-14 Prosensa Technologies B.V. Methods and means for treating dna repeat instability associated genetic disorders
JP5575486B2 (en) * 2007-01-18 2014-08-20 ユニヴァーシティ オブ ミズーリー−コロンビア Synthetic mini / micro-dystrophin gene that restores nNOS in the muscle sheath
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
NZ584793A (en) 2007-10-26 2012-05-25 Academisch Ziekenhuis Leiden Means and methods for counteracting muscle disorders
NZ587178A (en) 2008-02-08 2011-11-25 Prosensa Holding Bv Methods and means for treating dna repeat instability associated genetic disorders
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
JP2012524540A (en) 2009-04-24 2012-10-18 プロセンサ テクノロジーズ ビー．ブイ． Oligonucleotides containing inosine for treating DMD
EP2806900B1 (en) 2012-01-27 2021-12-15 BioMarin Technologies B.V. Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
GB201212456D0 (en) 2012-07-12 2012-08-29 Univ Sheffield Treatment of muscular dystrophy
EP2960336A1 (en) 2014-06-27 2015-12-30 Genethon Efficient systemic treatment of dystrophic muscle pathologies
WO2016115543A2 (en) 2015-01-16 2016-07-21 University Of Washington Novel micro-dystrophins and related methods of use
MA45477A (en) 2016-04-15 2019-02-20 Res Inst Nationwide Childrens Hospital ADENOASSOCIATED VIRUS VECTOR VECTOR MICROARN-29 AND MICRO-DYSTROPHINE TO TREAT MUSCLE DYSTROPHY
CA2971303A1 (en) 2016-06-21 2017-12-21 Bamboo Therapeutics, Inc. Optimized mini-dystrophin genes and expression cassettes and their use
EP3697915A4 (en) 2017-10-18 2021-12-08 Research Institute at Nationwide Children's Hospital Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy
KR20210082193A (en) * 2018-10-24 2021-07-02 브리스톨-마이어스 스큅 컴퍼니 Miniaturized dystrophin and uses thereof
WO2020193636A1 (en) * 2019-03-25 2020-10-01 Genethon Production of large-sized quasidystrophins using overlapping aav vectors
CN114207120A (en) 2019-05-30 2022-03-18 坚固生物科技公司 Recombinant herpesvirus vectors
WO2021089736A1 (en) 2019-11-06 2021-05-14 Association Institut De Myologie Combined therapy for muscular diseases
AU2021265103A1 (en) 2020-04-29 2023-01-19 Bristol-Myers Squibb Company Miniaturized dystrophins having spectrin fusion domains and uses thereof
WO2022076750A2 (en) 2020-10-07 2022-04-14 Regenxbio Inc. Recombinant adeno-associated viruses for cns or muscle delivery
RU2767335C1 (en) * 2021-03-02 2022-03-17 Общество с ограниченной ответственностью «Марлин Биотех» Chimeric proteins based on human utrophin and dystrophin and use thereof for treating duchenne muscular dystrophy
US20240191251A1 (en) 2021-04-05 2024-06-13 Solid Biosciences Inc. Recombinant herpesvirales vector
WO2023060269A1 (en) 2021-10-07 2023-04-13 Regenxbio Inc. Recombinant adeno-associated viruses for targeted delivery
WO2023212643A1 (en) * 2022-04-29 2023-11-02 University Of Washington Method for expressing a muscle-specific gene and cassettes for same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239060A (en) * 1986-07-25 1993-08-24 The Children's Medical Center Corporation Muscular dystrophy protein, dystrophin
US5541074A (en) * 1986-07-25 1996-07-30 The Children's Medical Center Corporation Antibodies to dystrophin and uses therefor
DE3852304T3 (en) 1987-03-02 1999-07-01 Enzon Lab Inc Organism as carrier for "Single Chain Antibody Domain (SCAD)".
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1990002909A1 (en) 1988-09-06 1990-03-22 Asarco Incorporated Method and burner for melting copper
US5096815A (en) * 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5198346A (en) * 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5686073A (en) * 1990-05-23 1997-11-11 The University Of Iowa Research Foundation Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein
US5308752A (en) * 1990-05-23 1994-05-03 Univ. Of Iowa Research Foundation Diagnosis of autosomal muscular dystrophy
US5260209A (en) * 1990-05-23 1993-11-09 University Of Iowa Research Foundation Nucleic acids encoding dystrophin-associated proteins
US5449616A (en) * 1990-05-23 1995-09-12 University Of Iowa Research Foundation Nucleic acid encoding dystrophin-associated protein
US5430129A (en) * 1991-01-16 1995-07-04 University Of Iowa Research Foundation Purified, native dystrophin
US5863743A (en) * 1994-08-12 1999-01-26 University Of Iowa Research Foundation Merosin deficiency-type congenital muscular dystrophy
GB9622174D0 (en) * 1995-12-19 1996-12-18 Medical Res Council Gene expression
US5994070A (en) * 1996-03-27 1999-11-30 Dana-Farber Cancer Institute Trio molecules and uses related thereto
EP1059354A2 (en) 1999-06-10 2000-12-13 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
CN100422320C (en) 2000-04-28 2008-10-01 肖啸 DNA sequences encoding dystrophin minigenes and methods of use thereof

Also Published As

Publication number Publication date
US20030216332A1 (en) 2003-11-20
ATE400656T1 (en) 2008-07-15
US8501920B2 (en) 2013-08-06
EP1366160A2 (en) 2003-12-03
DE60134786D1 (en) 2008-08-21
WO2002029056A3 (en) 2003-09-18
EP1366160B1 (en) 2008-07-09
US20080167260A1 (en) 2008-07-10
WO2002029056A2 (en) 2002-04-11
US6869777B2 (en) 2005-03-22
US20050049219A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
AU2001296600A1 (en) Mini-dystrophin nucleic acid and peptide sequences
WO2001075087A8 (en) Subtilisin variants
WO2005121331A3 (en) Truncated galnact2 polypeptides and nucleic acids
WO1999061619A3 (en) Cell cycle genes, proteins and uses thereof
WO2001047952A3 (en) Insecticidal proteins from bacillus thuringiensis
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
EP1159441B8 (en) Delivery of nucleic acids and proteins to cells
WO2002086144A3 (en) Compositions and methods for recombinational cloning of nucleic acid molecules
WO2005113592A3 (en) Interferon-alpha polypeptides and conjugates
WO2002006457A3 (en) Novel lipase genes
MX2010004371A (en) Streptomyces protease.
WO2005052143A3 (en) Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
WO2005121332A3 (en) Truncated st6galnaci polypeptides and nucleic acids
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
WO2004024750A3 (en) Cd44-binding ligands
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
WO2007052102A3 (en) Modified green fluorescent proteins and methods for using same
AU1172202A (en) Far red shifted fluorescent proteins
AU2003287115A1 (en) Fluorescent proteins from copepoda species and methods for using same
WO2001049721A3 (en) Bacterial genes and proteins that are essential for cell viability and their uses
WO1999010504A3 (en) Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
WO2003064614A3 (en) Transport peptides and uses therefor
WO2004087912A8 (en) Inhibitor proteins of a protease and use thereof
AU2001277554A1 (en) Preparation of a recombinant protein in a prokaryotic host cell by improved codon use